Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Development of Antibiotic Resistance

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...

Antibiotic Selection

Antibiotic Selection

Mechanism of Antibiotic Resistance in MRSA

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...

Clinical Significance of Antibiotic Resistance

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...

Microbiota Modulation by Antibiotics

Microbiota Modulation by Antibiotics

Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...

Defense Against Bacterial Pathogens

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Public contributions to the development of antibiotics: two successful and two failed investments.

Journal of pharmaceutical policy and practice·2026

Same author

Carbapenem-resistant Enterobacterales (CRE) acquisition and molecular characterization following colistin monotherapy and colistin-meropenem combination therapy: findings from the AIDA randomized trial.

Antimicrobial resistance and infection control·2025

Same author

The power of microbial life for the transformation towards a sustainable planet: key messages from the 2024 IUMS Congress in Florence, the city of the Renaissance.

microLife·2025

Same author

The global resistance problem and the clinical antibacterial pipeline.

Nature reviews. Microbiology·2025

Same author

Global health perspectives on antibacterial drug discovery and the preclinical pipeline.

Nature reviews. Microbiology·2025

Same author

'Piloting a framework for analysing the public contributions to R&D: new antibiotics in focus'.

Journal of pharmaceutical policy and practice·2025

Search research articles

Related Experiment Video

Updated: May 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Resistance drives antibacterial drug development.

Ursula Theuretzbacher¹

¹Center for Anti-Infective Agents, Eckpergasse 13, 1180 Vienna, Austria. utheuretzbacher@cefaia.com

Current Opinion in Pharmacology

|August 25, 2011

Summary

Antibacterial drug development faces evolving resistance. New drug analogs offer limited solutions, especially for Gram-negative bacteria, with no broad treatments on the horizon.

Area of Science:

Microbiology
Pharmacology
Infectious Diseases

Background:

Antibiotic resistance is a growing global challenge.
Development of new antibacterial drugs is crucial but complex.
Existing drug classes are under pressure from resistance mechanisms.

Purpose of the Study:

To review current trends in antibacterial drug development.
To assess the effectiveness of new analogs against multidrug-resistant pathogens.
To highlight the challenges in combating Gram-negative bacterial infections.

Main Methods:

Review of current clinical studies on antibacterial agents.
Analysis of resistance trends and their impact on drug efficacy.
Evaluation of new analogs for cephalosporins, oxazolidinones, glycopeptides, quinolones, aminoglycosides, tetracyclines, and ketolides.

More Related Videos

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Related Experiment Videos

Last Updated: May 30, 2026

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Nanomechanics of Drug-target Interactions and Antibacterial Resistance Detection

Published on: October 25, 2013

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Quadruple-Checkerboard: A Modification of the Three-Dimensional Checkerboard for Studying Drug Combinations

Published on: July 24, 2021

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Antibiotic Dereplication Using the Antibiotic Resistance Platform

Published on: October 17, 2019

Main Results:

New analogs of several established antibiotic classes are in clinical trials.
These new analogs provide only partial solutions to the crisis of multidrug-resistant pathogens.
Gram-negative bacteria remain a significant challenge, with limited progress in treatment options.

Conclusions:

The development of novel antibacterial agents is primarily driven by emerging resistance patterns.
Current strategies focusing on analogs of existing scaffolds offer insufficient solutions for widespread multidrug resistance.
There is an urgent need for fundamentally new approaches to treat infections caused by multidrug-resistant bacteria, particularly Gram-negative pathogens.